Vitamin B Supplementation with Rifampin: Benefits and Risks

Benefits of Vitamin B6 (Pyridoxine) Supplementation

The American College of Physicians and Infectious Diseases Society of America recommends vitamin B6 (pyridoxine) supplementation at 25-50 mg daily to prevent peripheral neuropathy in patients taking rifampin-containing tuberculosis regimens, particularly in high-risk patients 1
Pyridoxine specifically prevents peripheral neuropathy and central nervous system effects when given alongside isoniazid in TB treatment regimens, as recommended by the American Thoracic Society 2, 1

The Centers for Disease Control and Prevention recommends that the following patients receive pyridoxine 25-50 mg daily when on rifampin-containing regimens: pregnant women, breastfeeding infants, persons with HIV infection, patients with diabetes mellitus, patients with alcoholism, malnourished patients, patients with chronic renal failure, and elderly patients (advanced age) 1, 2, 3
For patients who develop peripheral neuropathy despite prophylaxis, the pyridoxine dose should be increased to 100 mg daily, as suggested by the Clinical Infectious Diseases society 1

Pyridoxine does NOT prevent rifampin-related hepatotoxicity or other hematological adverse events, according to the American Journal of Respiratory and Critical Care Medicine 2

Clinical monitoring should occur monthly for all patients on rifampin, with baseline liver function tests in selected high-risk cases, as recommended by the American College of Chest Physicians 2
The following parameters should be monitored: liver function tests at baseline (in elderly, those with liver disease, or alcohol consumers) and if symptoms develop, complete blood count and platelets at baseline in selected cases, symptoms of hepatotoxicity, and signs of peripheral neuropathy (if on isoniazid concurrently) 2, 4

The primary benefit of vitamin B supplementation is limited to preventing isoniazid-related peripheral neuropathy when these drugs are used together, and does not protect against rifampin's major toxicities (hepatotoxicity, drug interactions, or hematological effects), as stated by the Infectious Diseases Society of America 2, 1, 5, 3